Skip to main content
Toggle navigation
Login
Home
Favorite
Like
Post
Print
Jaejoon Song
U.S. Food and Drug Administration
Poster(s):
(A-315) Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System
Sunday, August 24, 2025
12:00 PM - 1:30 PM
ET
